Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2025-12-25 @ 1:23 AM
NCT ID:
NCT06167993
Eligibility Criteria:
Inclusion Criteria:
* Between the ages of 18-65,
* Having unilateral lower extremity or upper extremity lymphedema,
* Being diagnosed with Stage 2 and 3 lymphedema,
* Receiving lymphedema therapy for the first time,
* Adjuvant chemotherapy for gynecological cancer,
* Having completed radiation and surgical treatment at least 3 months and at most 5 years ago,
* Patients with lymph vessels seen on lymphangiography,
* Patients who have undergone LVA surgery and 1 month has passed since the surgery date
* No evidence of disease recurrence at last follow-up visit and
* Individuals willing to participate in the study
Exclusion Criteria:
* Those who do not volunteer to participate in the study,
* Those with bilateral lower extremity lymphedema,
* Having upper or lower extremity edema due to systemic disease,
* Those with active infection,
* Patients more than 1.5 months after LVA surgery
* Known to have mental and cognitive disorders
* Those who were unable to communicate and cooperate were not included.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT06167993
Study Brief:
Protocol Section:
NCT06167993